Fernando Camargo, Ph.D.

Professor, Harvard University and Boston Children’s Hospital

Dr. Fernando Camargo serves on the scientific advisory board for FogPharma.  He received a Ph.D. from Baylor College of Medicine in 2004, studying the developmental plasticity of adult somatic stem cells in the laboratory of Dr. Margaret Goodell.  Dr. Camargo then became a Whitehead Fellow at the Whitehead Institute for Biomedical Research, where he directed a laboratory focused on the regulation of stem cell proliferation and differentiation and the mechanisms that control tissue size in mammals. He joined Children’s Hospital and the Stem Cell and Regenerative Biology Department at Harvard University in 2009 where he is a full professor.  He has been the recipient of multiple awards including the NIH Director Innovator’s Award, the International Society of Stem Cell Research Outstanding Young Investigator Award, and the Vilcek Prize in Biomedical Sciences.  He is currently a Howard Hughes Medical Institute Scholar.

His laboratory’s ultimate goal is to understand the signals that regulate adult stem cell maturation and tissue regeneration. Currently, the main focus of the lab is the study and identification of the signals that regulate organ size and control tissue symmetry. His lab has pioneered the study of the Hippo/YAP signaling pathway as critical regulator of growth in multiple epithelial tissues. In addition, his research has shed light on the relationship between tissue size checkpoints and tumor suppression. His laboratory also has a strong interest in studying the cellular and molecular biology of hematopoietic stem cells.